1. Home
  2. QLGN vs CNET Comparison

QLGN vs CNET Comparison

Compare QLGN & CNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • CNET
  • Stock Information
  • Founded
  • QLGN 1996
  • CNET 2003
  • Country
  • QLGN United States
  • CNET China
  • Employees
  • QLGN N/A
  • CNET N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • CNET Advertising
  • Sector
  • QLGN Health Care
  • CNET Consumer Discretionary
  • Exchange
  • QLGN Nasdaq
  • CNET Nasdaq
  • Market Cap
  • QLGN 3.2M
  • CNET 3.2M
  • IPO Year
  • QLGN N/A
  • CNET N/A
  • Fundamental
  • Price
  • QLGN $4.07
  • CNET $1.63
  • Analyst Decision
  • QLGN
  • CNET
  • Analyst Count
  • QLGN 0
  • CNET 0
  • Target Price
  • QLGN N/A
  • CNET N/A
  • AVG Volume (30 Days)
  • QLGN 20.7K
  • CNET 30.2K
  • Earning Date
  • QLGN 11-14-2024
  • CNET 11-19-2024
  • Dividend Yield
  • QLGN N/A
  • CNET N/A
  • EPS Growth
  • QLGN N/A
  • CNET N/A
  • EPS
  • QLGN N/A
  • CNET N/A
  • Revenue
  • QLGN N/A
  • CNET $18,458,000.00
  • Revenue This Year
  • QLGN N/A
  • CNET N/A
  • Revenue Next Year
  • QLGN N/A
  • CNET N/A
  • P/E Ratio
  • QLGN N/A
  • CNET N/A
  • Revenue Growth
  • QLGN N/A
  • CNET N/A
  • 52 Week Low
  • QLGN $3.34
  • CNET $1.43
  • 52 Week High
  • QLGN $29.45
  • CNET $4.96
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 45.00
  • CNET 44.19
  • Support Level
  • QLGN $3.95
  • CNET $1.43
  • Resistance Level
  • QLGN $4.21
  • CNET $1.72
  • Average True Range (ATR)
  • QLGN 0.27
  • CNET 0.14
  • MACD
  • QLGN 0.00
  • CNET -0.02
  • Stochastic Oscillator
  • QLGN 22.08
  • CNET 30.30

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

Share on Social Networks: